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Most coronary arteriovenous ﬁstulae are congenital. They drain
nto cardiac chambers, coronary sinus, or pulmonary artery. Coro-
ary arteriovenous ﬁstulae may  be secondary to other conditions
uch as cardiac trauma, endomyocardial biopsies, aortic valve
eplacement, and coronary perforation complicating percutaneous
oronary intervention (PCI). Coronary perforation is a rare but dev-
stating complication of PCI with potentially fatal outcome. The
eported incidence of coronary perforations ranges from 0.1% to
.0% [1]. Women  and the elderly appear to be at higher risk of
erforation [2]. Ellis et al. [2] classiﬁed coronary perforation into
ype I: extraluminal crater without extravasation; type II: pericar-
ial or myocardial blush without a ≥1-mm exit hole; and type III:
rank streaming of contrast through a ≥1-mm exit hole, and cav-
ty spilling (i.e. coronary arteriovenous ﬁstula): perforation into
n anatomic cavity chamber, coronary sinus, etc. The incidence of
avity spilling was 0.02% [2].
Chronic total occlusion remains one of the more difﬁcult chal-
enges for coronary interventionists. Recent developments in the
reatment of chronic total occlusion involve the use of tapered
ydrophilic or very stiff guidewires. However, it is a trade-off for a
igher risk of coronary perforation. A recent study [3] has shown a
igh coronary perforation rate (7.4%) in patients with unsuccessful
CI for chronic total occlusion. Recently, a retrograde approach for
hronic total occlusion of coronary artery through a collateral chan-
el has been introduced. Cavity spilling from the septal artery into
he right or left ventricle rarely occurs as a complication of the retro-
rade approach through a septal channel. In the present case report
4], Park et al. showed coronary arteriovenous ﬁstula induced by
enetration of a guidewire for chronic total occlusion followed by
alloon inﬂation. All of the major epicardial coronary arteries have
n adjacent companion vein. However, the distance between coro-
ary arteries and veins are variable. Percutaneous in situ coronary
enous arterializations (PICVA) is the concept to use the in situ
oronary vein as the coronary artery for the treatment of chronic
otal occlusion [5]. The TransAccess catheter (TransVascular, Menlo
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Open access uPark, CA, USA) with a 24-gauge nitinol needle and phased array
ultrasound elements was  used to make a connection between the
coronary artery and the companion vein. In a previous study, PICVA
was attempted in 11 patients. In 6 patients, the adjacent vein could
not be adequately targeted for successful needle and wire delivery
because of variations in anatomy [5]. Thus it would be extremely
rare for a guidewire to penetrate from the coronary artery to the
companion vein.
Prolonged  balloon inﬂation, reversal anticoagulation, discontin-
uation of IIb/IIIa inhibitors if used, and platelet transfusion if needed
may be performed to seal coronary perforation. Guidewire-induced
coronary artery perforation may  be treated with transcatheter
delivery of autologous clots, microcoils, gelatin sponges, polyvinyl
alcohol, microﬁbrillar collagen, thrombin, and subcutaneous tissue
[6]. The conventional management often fails to seal perforation
especially when it is severe (i.e. type III) [1,2]. Before polyte-
traﬂuoroethylene (PTFE)-covered stents were available, type III
perforations were associated with a high incidence of major
adverse events (death, 19%; emergency bypass surgery, 63%; Q-
wave myocardial infarction, 15%; cardiac tamponade, 63%) [2].
Covered stents are a unique tool to seal perforation. Briguori et al.
[7] demonstrated a high successful rate (91%) for sealing type III
coronary perforation with PTFE-covered stents. In their study, clin-
ical outcomes were compared between patients treated with and
without PTFE-covered stents for coronary perforation that could
not be sealed by conventional management. The PTFE-covered
stent group had a lower incidence of non-Q-wave myocardial
infarction (0% vs. 47%, p = 0.005), cardiac tamponade (8% vs. 82%,
p < 0.001), blood transfusion (18% vs. 88%, p < 0.001), and bypass
surgery (18% vs. 88%, p < 0.01) [7].
Potential  complications of congenital coronary arteriovenous
ﬁstulae include pulmonary hypertension and congestive heart
failure if a large left-to-right shunt exists, bacterial endocardi-
tis, rupture or thrombosis of the ﬁstula or an associated arterial
aneurysm, and myocardial ischemia distal to the ﬁstula due to
decreased coronary blood ﬂow. The natural history of patients with
an acquired coronary artery ﬁstula is highly variable. It depends
on the magnitude of the shunt through the coronary arteriove-
nous ﬁstulae. Previous case reports demonstrated a benign clinical
course of iatrogenic coronary arteriovenous ﬁstulae. Youssef et al.
[8] showed spontaneous disappearance of an iatrogenic coronary
arteriovenous ﬁstula from a septal artery to the right ventricle.
A case report demonstrated disappearance of an iatrogenic coro-
nary arteriovenous ﬁstula due to neointimal hyperplasia in the bare
metal stent [9]. Iatrogenic coronary arteriovenous ﬁstulae may  be
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anaged medically without percutaneous or surgical intervention,
f patients are hemodynamically stable. In the present case [4], it
ight have been possible to manage the coronary arteriovenous
stula medically, especially unless the 2.0-mm balloon had been
nﬂated.
Iatrogenic coronary arteriovenous ﬁstulae with a large shunt
ay result in congestive heart failure and/or angina, especially if
he patient has reduced left ventricular function [10,11]. Elghoul
t al. [12] demonstrated usefulness of PTFE-covered stent to seal
n iatrogenic coronary arteriovenous ﬁstula after stenting. Another
ase report showed a case of an iatrogenic coronary arteriovenous
stula that was treated by coil embolization [10].
Iatrogenic coronary arteriovenous ﬁstula is a rate complication
f PCI. Many coronary interventionists may  have little experience.
hus it is important to know how to treat it in advance from case
eports.
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